Viewing Study NCT06922903


Ignite Creation Date: 2025-12-24 @ 7:34 PM
Ignite Modification Date: 2025-12-26 @ 10:13 PM
Study NCT ID: NCT06922903
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-04-13
First Post: 2025-04-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer.
Sponsor: Yunhe Pharmaceutical (Tianjin) Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module